Latest filing published 02 Apr 2026 for Annehem Fastigheter AB (publ), €1.6M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Pia Andersson (board member) discloses dealings in 3 companies, chiefly Annehem Fastigheter AB (publ), AnnehemFastigheter AB and Annexin Pharmaceuticals AB (publ). In total, 58 filings cover trades dated from 11 December 2020 to 2 April 2026.
On the open market, the record shows 34 purchases worth €20.0M and 5 sales worth €1.9M. On balance, insiders were net buyers of €18.1M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2026 to date brings 8 purchases and no sales.
In size, the median ticket on the buying side is €339k. Scaled by market value, the purchases weigh a median 0.34% of market cap (sample: 20 purchases). Of 31 purchases, 6 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
On 2 April 2026 came the latest disclosure, an open-market purchase for €1.6M in Annehem Fastigheter AB (publ). Between a trade and the moment it shows up on Finansinspektionen, the median delay is 1 day. For comparison, MAR article 19 gives managers three business days to notify a trade. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
23 of 23 declarations